RUNX3

Expression of RUNX3 gene in pancreatic adenocarcinoma and its clinical significance

L. - N. Xue, Bai, F. H., Wang, X. - Y., Lin, M., Tan, Y., Yao, X. - Y., and Xu, K. - Q., Expression of RUNX3 gene in pancreatic adenocarcinoma and its clinical significance, vol. 13, pp. 3940-3946, 2014.

We investigated the clinical significance of RUNX3 gene expression in human pancreatic carcinoma. Five samples of pancreatic tissues and 30 samples of pancreatic cancer tissues and paracancerous tissues were collected. RUNX3 expression was detected by real-time PCR and immunohistochemistry. The relationships between clinicopathological findings and the expression of RUNX3 were analyzed.

Relationship between RUNX3 methylation and hepatocellular carcinoma in Asian populations: a systematic review

X. X. Lu, Zhu, L. Q., Pang, F., Sun, W., Ou, C., Li, Y., Cao, J., and Hu, Y. L., Relationship between RUNX3 methylation and hepatocellular carcinoma in Asian populations: a systematic review, vol. 13, pp. 5182-5189, 2014.

Runt-related transcription factor 3 (RUNX3) is a potential tumor suppressor that is frequently hypermethylated in hepatocellular carcinoma (HCC). The present meta-analysis of case-control studies was carried out to determine whether RUNX3 hypermethylation is associated with HCC. The PubMed, Embase, and Chinese National Knowledge Infrastructure databases were searched for all relevant studies published between May 2000 and May 2012.

Subscribe to RUNX3